Of interest, reports have showed that ART suppressed tumor growth and progression through inhibiting the NF-κB pathway in many cell lines, including prostate cancer cells, human cervical carcinoma cells [81], and human erythroleukemic cells [82]. Here, NFKB1 is linked to prostate carcinoma.